Biotech. Stocks to Watch: Arena Pharmaceuticals, VIVUS, U.S. Peregrine Pharmaceuticals, PDL BioPharma Inc

Lakeway, TX -- (SBWIRE) -- 02/26/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) went down 1.31% and closed at $8.27. Arena Pharmaceuticals, Inc. (Arena) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors (GPCRs), in four therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

How Should Investors Trade ARNA After The Recent Movement? Find Out Here

VIVUS, Inc.(NASDAQ:VVUS) is lower 1.36% and closed at $12.41. VIVUS, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutic drugs for underserved markets, including obesity and related morbidities, such as sleep apnea and diabetes, and men's sexual health.

Is VVUS Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Peregrine Pharmaceuticals(NASDAQ:PPHM) fell 12.03% and closed at $1.39. Peregrine Pharmaceuticals, Inc. (Peregrine) is a biopharmaceutical company developing monoclonal antibodies for the treatment and diagnosis of cancer. The Company's pipeline of investigational monoclonal antibodies is based on two technology platforms, including PS-targeting antibodies and DNA/histone-targeting antibodies.

Is PPHM a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

PDL BioPharma Inc.(NASDAQ:PDLI) moved down 1.14% and closed at $6.95. PDL BioPharma, Inc. (PDL) is a is a biotech company. PDL is engaged in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies.

How Should Investors Trade PDLI After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.